This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. With offices in London and the Middle East, Themis has ...

Themis, a collaborative governance, risk, and compliance platform, recently announced thatit has secured $9 million in seed investment “to solve compliance and risk challenges stemming from ...

Themis Bioscience has postponed its planned IPO in Amsterdam. The Austrian biotech is now looking into “all strategic options” to secure the cash it needs to move its chikungunya vaccine into phase 3.

MANILA, Philippines — Themis Group Corp. is set to commence next week its tender offer for all the common shares of listed Ferronoux Holdings Inc. held by public shareholders as part of its backdoor ...